Tumor-secreted protein may lead to better treatments for brain tumors: Endocan, which is produced by endothelial cells lining blood vessels of tumors, activates PDGFRA, a receptor on glioblastoma cells that drives tumor growth and makes the cancer resistant to standard therapies